B Ledergerber
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Hirsch H, Hasse B, Metzner K, Müller N, Weber R, Wandeler G, Vernazza P, Trkola A, Tarr P, Stöckle M, Speck R, Schmid P, Scherrer A, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H, Fux C, Kouyos R, Günthard H, Hoffmann M, Furrer H, Cavassini M, Calmy A, Bernasconi E, Battegay M, Klimkait T, Aubert V, Yerly S, Böni J, Kadelka C, Bachmann N, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H, Braun D, Böni J, Bernasconi E, Battegay M, Turk T. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. Elife 2017; 6
Sep 12, 2017Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
Sep 12, 2017Elife 2017; 6
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R D, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Hirsch H H, Hasse B, Metzner K J, Müller N, Weber R, Wandeler G, Vernazza Pietro, Trkola A, Tarr P, Stöckle M, Speck R, Schmid Patrick, Scherrer A U, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H F, Fux C A, Kouyos Roger D, Günthard Huldrych F, Hoffmann Matthias, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Aubert Vincent, Yerly Sabine, Böni Jürg, Kadelka Claus, Bachmann Nadine, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H C, Braun D L, Böni J, Bernasconi E, Battegay M, Turk Teja
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population
Bochud M, Simone E, Andrea F, Frei M, Claudius F, Jakob F, Ali G, Matthias G, Denis H, Marcel H, Walter H, Simon H, Felix H, Paul H, Eva K, Kaplan V, Peter D, Corinne C, Jean Michel G, Christoph H, Thomas L, Pedro M, Paccaud F, von Känel R, Aidacic V, Jürg B, Markus B, Heinz B, Martin B, Hans-Ulrich B, Ivo B, Reto C, Isabelle C, Daniel K, Stephan K, Beat K, Georg S, Pietro S, Jacques S, Alfred S, Alois S, Claudia S, Othmar S, Phuoc T, Marco V, Alessandro V, René V, Hans W, Fritz W, Johanna W, Joseph W, Frank S, Hana S, Benedict K, Heidi K, Vesna L, Giovanni L, Werner L, Phillippe L, Severin L, Christoph M, Jürgen M, Damian M, Werner M, Titus M, Valentina N, Jakob R, Rosemann T, Marco Z, Hasse B, CoLaus Cohort, FIRE and the Swiss HIV Cohort Study, Aubert V, Barth J, Battegay M, Bernasconi E, Böni J, Bucher H, Burton-Jeangros C, Calmy A, Cavassini M, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Ledergerber B, Vollenweider P, Tarr P, Marques-Vidal P, Waeber G, Preisig M, Mooser V, Valeri F, Djalali S, Rauch A, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Battegay M, Weber R, Senn O, Fux C, Gorgievski M, Günthard H, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid P, Schultze D, Schüpbach J, Speck R, Staehelin C, Tarr P, Telenti A, Trkola A, Weber R, Yerly S, Pantaleo G, Nadal D, Haerry D, Hasse B, Hirsch H, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Jean-Michel A. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis 2015; 2:ofv108.
Jul 8, 2015Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population
Jul 8, 2015Open Forum Infect Dis 2015; 2:ofv108
Bochud Murielle, Simone Erni, Andrea Forster, Frei Markus, Claudius Frey, Jakob Frey, Ali Gibreil Musa, Matthias Günthard, Denis Haller, Marcel Hanselmann, Walter Häuptli, Simon Heininger, Felix Huber, Paul Hufschmid, Eva Kaiser, Kaplan Vladimir, Peter Duner, Corinne Chmiel, Jean Michel Gaspoz, Christoph Hock, Thomas Lüscher, Pedro Marques Vidal, Paccaud Fred, von Känel Roland, Aidacic Vladeta, Jürg Beriger, Markus Bertschi, Heinz Bhend, Martin Büchi, Hans-Ulrich Bürke, Ivo Bugmann, Reto Cadisch, Isabelle Charles, Daniel Klaus, Stephan Koch, Beat Köstner, Georg Schlatter, Pietro Somaini, Jacques Staeger, Alfred Staehelin, Alois Steinegger, Claudia Steurer, Othmar Suter, Phuoc Truong The, Marco Vecellio, Alessandro Violi, René Von Allmen, Hans Waeckerlin, Fritz Weber, Johanna Weber-Schär, Joseph Widler, Frank Schindelek, Hana Sajdl, Benedict Kuster, Heidi Kuster, Vesna Ladan, Giovanni Lauffer, Werner Leibundgut Hans, Phillippe Luchsinger, Severin Lüscher, Christoph Maier, Jürgen Martin, Damian Meli, Werner Messerli, Titus Morger, Valentina Navarro, Jakob Rizzi, Rosemann Thomas, Marco Zoller, Hasse Barbara, CoLaus Cohort, FIRE and the Swiss HIV Cohort Study, Aubert V, Barth J, Battegay M, Bernasconi E, Böni J, Bucher H C, Burton-Jeangros C, Calmy A, Cavassini M, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Ledergerber Bruno, Vollenweider Peter, Tarr Philip E, Marques-Vidal Pedro, Waeber Gerard, Preisig Martin, Mooser Vincent, Valeri Fabio, Djalali Sima, Rauch Andri, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Battegay Manuel, Weber Rainer, Senn Oliver, Fux C A, Gorgievski M, Günthard H, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid Patrick, Schultze D, Schüpbach J, Speck R, Staehelin C, Tarr P, Telenti A, Trkola A, Weber R, Yerly S, Pantaleo G, Nadal D, Haerry D, Hasse B, Hirsch H H, Hösli I, Kahlert Christian, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Jean-Michel Aubry
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
Schaerer V, Rauch A, Fehr J, Metzner K, Furrer H, Günthard H, Böni J, Aouri M, Decosterd L, Schmid P, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study. Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Med 2015; 16:599-607.
Jul 2, 2015Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
Jul 2, 2015HIV Med 2015; 16:599-607
Schaerer V, Rauch A, Fehr J, Metzner K J, Furrer H, Günthard H F, Böni J, Aouri M, Decosterd L, Schmid Patrick, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study
Increases in Condomless Sex in the Swiss HIV Cohort Study
Yerly S, Müller N, Metzner K, de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Nadal D, Nicca D, Weber R, Vernazza P, Trkola A, Tarr P, Speck R, Schüpbach J, Schmid P, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Hirsch H, Hasse B, Bernasconi E, Battegay M, Aubert V, Swiss HIV Cohort Study, Günthard H, Weber R, Bernasconi E, Vernazza P, Stöckle M, Furrer H, Cavassini M, Calmy A, Hasse B, Böni J, Bucher H, Haerry D, Günthard H, Gorgievski M, Fux C, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Kouyos R. Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis 2015; 2:ofv077.
Jun 3, 2015Increases in Condomless Sex in the Swiss HIV Cohort Study
Jun 3, 2015Open Forum Infect Dis 2015; 2:ofv077
Yerly S, Müller N, Metzner K, de Tejada B Martinez, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Nadal D, Nicca D, Weber R, Vernazza P, Trkola A, Tarr P, Speck R, Schüpbach J, Schmid Patrick, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Hirsch H H, Hasse B, Bernasconi E, Battegay M, Aubert V, Swiss HIV Cohort Study, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Stöckle Marcel, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Hasse Barbara, Böni J, Bucher H C, Haerry D, Günthard H, Gorgievski M, Fux C A, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Kouyos Roger D
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013
Yerly S, Metzner K, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Hirsch H, Hasse B, Müller N, Nadal D, Weber R, Vernazza P, Trkola A, Telenti A, Tarr P, Speck R, Schüpbach J, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Nicca D, Haerry D, Günthard H, Gorgievski M, Rauch A, Furrer H, Salazar-Vizcaya L, Keiser O, Bernasconi E, Schmid P, Stöckle M, Cavassini M, Ambrosioni J, Fehr J, Metzner K, Rohrbach J, Jaquier M, Schlauri M, Swiss HIV Cohort Study, Aubert V, Fux C, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Bucher H, Böni J, Bernasconi E, Battegay M, Wandeler G. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis 2015; 2:ofv026.
Mar 25, 2015Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013
Mar 25, 2015Open Forum Infect Dis 2015; 2:ofv026
Yerly S, Metzner K, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Hirsch H H, Hasse B, Müller N, Nadal D, Weber R, Vernazza Pietro, Trkola A, Telenti A, Tarr P, Speck R, Schüpbach J, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Nicca D, Haerry D, Günthard H, Gorgievski M, Rauch Andri, Furrer Hansjakob, Salazar-Vizcaya Luisa, Keiser Olivia, Bernasconi Enos, Schmid Patrick, Stöckle Marcel, Cavassini Matthias, Ambrosioni Juan, Fehr Jan, Metzner Karin J, Rohrbach Janine, Jaquier Marie-Eve, Schlauri Marion, Swiss HIV Cohort Study, Aubert V, Fux C A, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Bucher H C, Böni J, Bernasconi E, Battegay M, Wandeler Gilles
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
Schäfer J, Bucher H, Battegay M, Furrer H, Cavassini M, Calmy A, Nicca D, Ledergerber B, Bernasconi E, Young J, Swiss HIV Cohort Study. Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2014; 16:3-14.
May 8, 2014Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
May 8, 2014HIV Med 2014; 16:3-14
Schäfer J, Bucher Hc, Battegay M, Furrer H, Cavassini M, Calmy A, Nicca Dunja, Ledergerber B, Bernasconi E, Young J, Swiss HIV Cohort Study
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2012
Sep 24, 2012Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Sep 24, 2012HIV Med 2012
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza Pietro, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13:387-97.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV Med 2012; 13:387-97
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca Dunja, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine 2012; 13:387-397.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV medicine 2012; 13:387-397
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter Rafael, Ledergerber B, Swiss HIV Cohort Study Group
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Thierfelder C, Ledergerber B, Gutmann C, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med 2011; 13:118-26.
Nov 22, 2011Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Nov 22, 2011HIV Med 2011; 13:118-26
Thierfelder C, Ledergerber B, Gutmann Christine, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*). HIV Med 2010
Oct 18, 2010Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Oct 18, 2010HIV Med 2010
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS)
How reliable is an undetectable viral load?
Combescure C, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study. How reliable is an undetectable viral load?. HIV medicine 2009; 10:470-6.
Sep 1, 2009How reliable is an undetectable viral load?
Sep 1, 2009HIV medicine 2009; 10:470-6
Combescure Christophe, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
Weber R, Ledergerber B, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Furrer H, Rickenbach M, Huber M, Swiss HIV Cohort Study. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV medicine 2009; 10:407-16.
Aug 1, 2009Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
Aug 1, 2009HIV medicine 2009; 10:407-16
Weber R, Ledergerber B, Schmid Patrick, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Furrer H, Rickenbach M, Huber M, Swiss HIV Cohort Study
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J, Vernazza P, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA : the journal of the American Medical Association 2001; 286:2560-7.
Nov 28, 2001HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Nov 28, 2001JAMA : the journal of the American Medical Association 2001; 286:2560-7
Phillips A N, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J D, Vernazza Pietro, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group
Importance of mental health assessment in HIV-infected outpatients
Zinkernagel C, Battegay M, Vernazza P, Werder V, Kiss A, Rauchfleisch U, Volkart A, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study. Importance of mental health assessment in HIV-infected outpatients. Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9.
Nov 1, 2001Importance of mental health assessment in HIV-infected outpatients
Nov 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9
Zinkernagel C, Battegay M, Vernazza Pietro, Werder V, Kiss A, Rauchfleisch U, Volkart A C, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza P, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:1322-7.
Oct 20, 2001Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Oct 20, 2001Lancet 2001; 358:1322-7
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza Pietro, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J, Boggian K, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-5.
Nov 25, 2000Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Nov 25, 2000Lancet 2000; 356:1800-5
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J C, Boggian Katia, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Rutschmann O, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H, Vernazza P, Hirschel B. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS (London, England) 2000; 14:2145-51.
Sep 29, 2000Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Sep 29, 2000AIDS (London, England) 2000; 14:2145-51
Rutschmann O T, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H C, Vernazza Pietro, Hirschel B
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
Ledergerber B, Francioli P, Sudre P, Kaufmann D, Opravil M, Bernasconi E, Vernazza P, Battegay M, Furrer H, Hirschel B, Weber R, Erard V, Egger M, Telenti A. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA : the journal of the American Medical Association 1999; 282:2220-6.
Dec 15, 1999AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
Dec 15, 1999JAMA : the journal of the American Medical Association 1999; 282:2220-6
Ledergerber B, Francioli P, Sudre P, Kaufmann D, Opravil M, Bernasconi E, Vernazza Pietro, Battegay M, Furrer H, Hirschel B, Weber R, Erard V, Egger M, Telenti A
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study
Zinkernagel C, Ledergerber B, Battegay M, Cone R, Vernazza P, Hirschel B, Opravil M. Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. AIDS (London, England) 1999; 13:1587-9.
Aug 20, 1999Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study
Aug 20, 1999AIDS (London, England) 1999; 13:1587-9
Zinkernagel C, Ledergerber B, Battegay M, Cone R W, Vernazza Pietro, Hirschel B, Opravil M